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RATIONALE: Thiodiglycolic acid (TDGA) is a urinary metabolite of the oxazaphosphorine class of chemotherapeutics, in
particular of ifosfamide. Ifosfamide metabolism generates chloroacetaldehyde (CAA), a toxic compound associated with
neurotoxicity, nephrotoxicity, urotoxicity and cardiotoxicity. CAA, in turn, interacts with cellular thiol groups leading to
GSH depletion, cell death and generation of thiodiglycolic acid (TDGA), as a ﬁnal product. TDGA is mainly excreted in
the urine. The ability to accurately measure TDGA in urine, therefore, will be a useful way of monitoring exposure to
ifosfamide during chemotherapy.
METHODS: TDGA in urine samples was measured with liquid chromatography coupled to mass spectrometry (LC/MS)
by means of a novel Surface-Activated Chemical Ionization–Electrospray (SACI–ESI) or a classical ESI ion source alone.
RESULTS: The SACI–ESI and ESI alone based methods for analysis of urinary TDGAwere optimized and compared. A
strong reduction in matrix effect together with enhanced quantiﬁcation performances was obtained with the SACI–ESI
when compared with ESI. In particular, an increase in quantiﬁcation precision (from 85 to 95%) and accuracy (from 59
to 90%) were observed, which allowed for optimal detection of TDGA.
CONCLUSIONS: The LC/SACI–ESI-MS approach provides a very sensitive and quantitative method for the analysis of
TDGA. Thanks to the enhancement in sensitivity and matrix effect reduction, the SACI–ESI source enables the use of a
relatively low-cost ion-trapmass spectrometer in the analysis of this toxicity biomarker in urine. Due to these characteristics,
this approach would constitute an invaluable tool in the clinical laboratory, for measuring TDGA and other toxicity related
biomarkers of chemotherapy with proper sensitivity and accuracy. Copyright © 2012 John Wiley & Sons, Ltd.
(wileyonlinelibrary.com) DOI: 10.1002/rcm.6471The oxazaphosphorines (cyclophosphamide, ifosfamide and
trofosfamide) are widely used in clinical practice for their
anti-tumor and immuno-modulatory activities. These drugs,
however, have associated neurotoxicity, nephrotoxicity, uro-
toxicity and cardiotoxicity.[1–7] Cytochrome P450 metabolism
of ifosfamide leads to formation of highly reactive meta-
bolites, in particular acrolein and chloroacetaldehyde, which
are considered to be responsible for the major associated toxi-
cities.[2,4,5,7] The interaction of chloroacetaldehyde with cellu-
lar molecules containing thiol groups (e.g. glutathione and
cysteine) results in the generation of the downstream metabo-
lite thiodiglycolic acid (TDGA),[6] which is also related to toxi-
city.[5,7] The cascade of metabolic events that leads to CAA
and TDGA formation is given in Scheme 1. TDGA is a low
molecular weight metabolite (MW: 150 Da) with two highly
polar acid groups (see Scheme 1). CAA is very difﬁcult to* Correspondence to: A. Albini, IRCCS MultiMedica, Polo
Scientiﬁco e Tecnologico, Via Fantoli 16/15, 20138Milan, Italy.
E-mail: albini.adriana@gmail.com
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leads to its rapid depletion.[1] TDGA is a quantitative reaction
product of CAA, detectable and quantiﬁable in urine due to a
better stability and higher polarity. It represents a useful
biomarker of CAA elimination. Since the metabolism of
ifosfamide to CAA depends on numerous inducible cyto-
chrome P450 isoforms, measurement of TDGA in the urine
provides a simple approach to estimate CAA generation
during ifosfamide chemotherapy, allowing for adjustments
in dosage and schedule. Different methods have been devel-
oped to quantify TDGA in serum and urine.[8–12] One valid
approach was to quantify TDGA using capillary electrophor-
esis coupled with an ultraviolet absorbance detector (CE-UV).
This method exhibits high sensitivity (the limit of quantiﬁca-
tion (LOQ) between 5–10 micrograms/L)[12] but with lower
selectivity as compared to a separation technology coupled
to a mass spectrometric analyzer. Other groups developed
approaches based on gas chromatography/mass spectrome-
try (GC/MS).[8,10,11] However, despite its high selectivity
and sensitivity, time-consuming sample extraction and pre-
paration procedures make it unsuitable for modern highCopyright © 2012 John Wiley & Sons, Ltd.
Scheme 1. Cascade of metabolic events that leads to CAA and TDGA formation.
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47productivity clinical laboratories. Recently, two different
approaches based on ultra-performance liquid chromato-
graphy/high-resolution and mass accurate time-of-ﬂight
mass spectrometry (UPLC/TOF-MS) technology have been
developed to quantify different chemotherapy-related toxi-
city biomarkers, including TDGA.[9,13] This technology makes
it possible to obtain a high chromatographic resolution, redu-
cing the matrix effect ionization effect[14] that lowers quantiﬁ-
cation precision and accuracy in the analysis of biological
samples. The high mass accuracy of the TOF analyzer makes
it possible to obtain high selectivity and sensitivity. Despite
the remarkable performance of this solution, its costs are quite
high for many laboratories’ budget. Therefore, development of
less expensive, although performing technology would be an
interesting option for monitoring toxic metabolites.
One approach that has been explored to efﬁciently reduce
the matrix effect without using an UPLC system is to employ
low voltage ionization sources such as the no discharge atmo-
spheric pressure chemical ionization (ND-APCI),[15,16] a
detection technology developed by Cristoni et al.[17,18] In this
case, an APCI source was employed to ionize analytes with-
out using high-voltage corona discharge. Under these condi-
tions both the spectrum chemical noise and matrix effect
signiﬁcantly decrease, leading to a stable analyte quantiﬁcation.
An improvement of ND–APCI, now named surface-activated
chemical ionization (SACI), has been developed in order to
increase the signal/noise (S/N) ratio.[19] In SACI the ionization
efﬁciency is increased by inserting a surface placed at low
voltage (50–400 V) that activates a gas-phase solvent polari-
zation and proton reaction mechanism. Recently, the SACI
phenomenon has been exploited to enhance the performance
of electrospray ionization (ESI) further in terms of matrix effect
reduction, quantiﬁcation precision and accuracy and sensitivity
(SACI–ESI).[20,21] In the SACI–ESI ionization approach, sampleCopyright © 2012 JRapid Commun. Mass Spectrom. 2013, 27, 476–480ionization involves both the Ion Evaporation (IEM) model and
Charge Reaction (CRM) models,[22] along with the impact of a
quota of charged droplets with the SACI surface. This improves
the ion gasiﬁcation efﬁciency. In addition, the electric ﬁeld of
the metallic surface in the SACI source, which is placed at an
angle of about 45 relative to the axis of the ESI spray cone, acts
as an ion deﬂector, pushing ions towards the entry oriﬁce of the
mass analyzer. This allows a reduction in the chemical noise
due to the extra-charged solvent environment and an increase
in analyte ion signal due to the high efﬁciency of ESI ionization
combined with the SACI ion impact evaporation and focaliza-
tion effects.
Here we describe a new high-throughput approach (5 min
of total sample run time) based on the highly efﬁcient and
less expensive liquid chromatography (LC)/SACI–ESI
tandem mass spectrometry (MS/MS) method that was devel-
oped to quantify TDGA as a toxicology biomarker. The new
approach (LC/SACI–ESI-MS/MS) was compared with
the classical liquid chromatography/electrospray ionization
tandem mass spectrometry (LC/ESI-MS/MS) method, and
the beneﬁts, mainly in terms of matrix effect reduction, quan-
tiﬁcation, precision, accuracy, sensitivity and sample through-
put, are shown.EXPERIMENTAL
Chemicals
The normal and deuterated (D3) standard TDGA as well
as formic acid were purchased from Sigma-Aldrich (Milan,
Italy). Methanol and water were purchased from Romil
(Cambridge, UK).wileyonlinelibrary.com/journal/rcmohn Wiley & Sons, Ltd.
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Figure 1. Direct infusion spectra of a 500 ng/mL aqueous
solution of TDGA standard obtained using both the (a) ESI
and (b) SACI–ESI approaches. The syringe sample ﬂow rate
was 10 mL/min.
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478Urine sample preparation
Urine (100 mL) was diluted 2-fold with doubly distilled water
and two different urine samples that contained spiked
500 ng/mL TDGAwere used during the development of the
LC/MS and MS/MS procedures.
A calibration curve was prepared in water with 1, 2, 5, 20
and 50 ng/mL TDGA. The matrix effect was determined by
the addition of TDGA standards at the concentrations of 5
and 50 ng/mL. The level of TDGA in each sample was deter-
mined from the ratio of the peak area of TDGA to that of the
TDGAD3 internal standard.
Chromatography
A fast isocratic chromatography was performed using an
Ultimate 3000 HPLC system (DIONEX, Sunnyvale, CA, USA)
with an Aquasil C18 LC column (100 2.1 mm, 3 mm, 100 Å;
Thermo Scientiﬁc, San Jose, CA, USA).
During the analysis an isocratic condition was employed
using H2O+0.5% (v/v) formic acid (phase A)/acetonitrile
(CH3CN+0.5% (v/v) (98:2) formic acid (phase B). The acqui-
sition time was 3 min. After ﬁve analyses, a column washing
step (0 min, 2% B; 0 to 1 min, a linear gradient of 0% to 80% B;
1 to 5 min, isocratically 80%B) was used to clean the column
from residual urine metabolites; followed by re-equilibration
to starting conditions for a further 5 min. Considering this
washing step the average total run time (TRT) for each analy-
sis was 5 min. The ﬂow rate was 100 mL/min.
Mass spectrometry
Mass spectra were acquired using an LTQ ion trap spectro-
meter (Thermoelectron, San Jose, CA, USA) in negative acqui-
sition mode. Three microscans for each spectrum were
acquired in the positive mode. A rolling average of four spec-
tra was also used. ESI and SACI–ESI ionization approaches
were employed, which were coupled to MS and MS/MS ana-
lyzers. The ion isolation width used for MS/MS was 2m/z
units. The collision energy was set to 60% of the maximum
value. The ESI spray voltage was 4500 V, the nitrogen drying
gas temperature was 350 C and its ﬂow was 8 L/min. The
nebulizing gas (nitrogen) ﬂow was 10 L/min. The SACI–ESI
spray voltage was 1500 V, the nitrogen drying gas tempera-
ture was 350 C and its ﬂow was 8 L/min. The SACI surface
voltage was 150 V. The nebulizing gas (nitrogen) ﬂow was
10 L/min.
Data analysis
Xcalibur software (Thermoﬁsher, San Jose, CA, USA) was
used for data acquisition. Qual- and QuanBrowser (Thermo-
Fisher, San Jose, CA, USA) were employed for data elabora-
tion. The signal/noise (S/N) ratio was calculated using the
Root Mean Square (RMS) algorithm.[23]RESULTS AND DISCUSSION
Initial experiments employed a direct infusion. A standard
500 ng/mLTDGA aqueous solution was analyzed using both
the ESI and SACI–ESI approaches. Figures 1(a) and 1(b) show
the direct infusion spectra. As can be seen, the S/N ratio ofwileyonlinelibrary.com/journal/rcm Copyright © 2012 John Withe [M–H]– ion signal at m/z 149 is deﬁnitely higher using
SACI–ESI. Under ESI conditions, the RMS calculated S/N
ratio was 1020 while with SACI–ESI the value increased to
4010. It must be emphasized that the increase in S/N ratio
is mainly due to two joined contributions:
A) The higher [M–H]– signal intensity that increases
from 1.54 105 under ESI conditions to 3.06 105 using
SACI–ESI; this phenomenon is due to the sum of electro-
spray and SACI solvent polarization ionization effects.
B) The lower spectrum chemical noise observed under
SACI–ESI conditions. Under the ESI conditions an aver-
age background noise of 1.2 102 was observed while
in SACI–ESI it drops down to 5.2 101. This decrease
is mainly due to the lower amount of solvent cluster
ion species usually obtained under the lower voltage
SACI–ESI ionization conditions.[18,19,21]
The MS/MS spectrum was obtained by fragmentation of
the [M–H]– precursor ion of TDGA at m/z 149 in order to
increase the S/N ratio and instrumental speciﬁcity. This
fragmentation spectrum is shown in Fig. 2. An abundant
CO2 neutral loss was observed, leading to the fragment ion
at m/z 105.
A high-throughput 3-min isocratic chromatography was
performed under both LC/ESI-MS/MS and LC/SACI–
ESI-MS/MS conditions in order to analyze urine samples and
evaluate the matrix effect suppression. Isocratic conditions
were maintained using an H2O/CH3CN elution phase with
0.5% (v/v) formic acid. This formic acid concentration is funda-
mental. On one hand, the acid solution environment should
help the deprotonation of the TDGA acid molecule in the ioni-
zation source while, on the other hand, it makes it possible to
better retain compounds on the C18 stationary phase of choice.
During the chromatographic separation, the TDGAacid groupsley & Sons, Ltd. Rapid Commun. Mass Spectrom. 2013, 27, 476–480
Figure 2. Direct infusion MS/MS spectrum of the [M–H]–
precursor ion of TDGA at m/z 149. The syringe sample ﬂow
rate was 10 mL/min.
SACI–ESI in thiodiglycolic acid analysis(see Scheme 1) are protonated, decreasing the analyte polarity
and consequently producing improved column retention. The
SACI polarization effect taking place in the SACI–ESI ioniza-
tion source helps to reduce the TDGA proton afﬁnity, conse-
quently increasing ionization efﬁciency even under acid solvent
conditions. Figures 3(a) and 3(b) show the LC/ESI-MS/MS ion
extraction mass chromatogram obtained by monitoring a ﬁnal
concentration 50 ng/mL of TDGA in spiked bi-distilled water
and urine, in both cases diluted 1:10 with bi-distilled water
before analysis. In this case, a strong matrix suppression
effect is observed in urine. In fact, the chromatographic RMS
S/N ratio undergoes about a 3-fold decrease, the measured
S/N ratio dropping from a value of 300 in water to a value of
90 in urine.
Figures 3(c) and 3(d) show the same analyses performed
with the LC/SACI–ESI-MS/MS apparatus. Not only is the
S/N ratio obtained for the compound in water about two
times higher than that obtained with the optimized LC/ESI-
MS/MS conditions, but a clear reduction in matrix ionFigure 3. LC/ESI-MS/MS ion extractionmass chromatograms
obtained by monitoring a ﬁnal concentration 50 ng/mL of
TDGA in (a) bi-distilled water and (b) spiked urine diluted
1:10 with bi-distilled water. LC/SACI–ESI-MS/MS ion extrac-
tion mass chromatograms obtained by monitoring a ﬁnal
concentration 50 ng/mL of TDGA in (c) bi-distilled water and
(d) spiked urine diluted 1:10 with bi-distilledwater. The sample
injection volume was 10 mL.
Copyright © 2012 JRapid Commun. Mass Spectrom. 2013, 27, 476–480suppression effect is also observed. In fact, the reduction in
the S/N ratio in urine is only of 21%, the measured S/N ratio
dropping from a value of 610 in water to a value of 482 in
urine. This was probably due to the fact that the SACI–ESI
source can be operated at a lower voltage than that used with
the ESI source alone. It must be emphasized that a weak
thyodyglicolic acid retention time shift of 0.07 min has been
observed when comparing the bi-distilled water and urine
analyses (Figs. 3(c) and 3(d)). This is probably due to prog-
ressive column stationary phase degradation due to matrix–
column interactions. In particular, the column life under the
experimental conditions used here was approximately 550
urine samples.
We then compared the LC/ESI- and LC/SACI–ESI-MS/MS
ionization approaches for quantiﬁcation performance in
terms of limit of detection (LOD), limit of quantiﬁcation
(LOQ), linearity range, precision and accuracy. The results
obtained are shown in Table 1. The SACI–ESI approach exhi-
bits, in general, better performance with respect to the ESI
approach alone. In particular, a strong increase in sensitivity
was observed: the absolute LOD value changed from 5 ng/mL
to 1 ng/mL, while the absolute LOQ value went from
10 ng/mL to 3 ng/mL, with ESI and SACI–ESI, respectively.
Another strong beneﬁt was obtained in terms of quantiﬁca-
tion precision and accuracy. These beneﬁts are likely due to the
reduction in the matrix effect achieved under the SACI–ESI
operating conditions. All these parameters were measured
by analyzing two urine samples spiked with different concen-
trations of TDGA (50 and 200 ng/mL). Table 2 shows the
results obtained in terms of precision and accuracy for
each sample using both the LC/ESI- and LC/SACI–ESI-
MS/MS approaches. The average precision increased from
85 to 95% and average accuracy from 59 to 90% with LC/
SACI–ESI-MS/MS.CONCLUSIONS
A rapid, optimized and cost-effective method for the analy-
sis of TDGA, a biomarker of ifosfamide toxicity, in urine
has been developed. The new method is based on the
innovative SACI–ESI ionization system coupling LC with
a relatively inexpensive ion-trap MS analyzer. This novel
technology leads to a signiﬁcant increase in performances,
both in terms of sensitivity (LOQ) and quantiﬁcation (LOD,
precision and accuracy), when compared with a classical ESI
ionization system.
Future studies will be devoted to testing this approach in
monitoring oxazaphosphorinemetabolites during chemotherapy.Table 1. Comparative table reporting the limit of detection
(LOD), limit of quantiﬁcation (LOQ), linearity range,








ESI 5 10 10–250
SACI–ESI 1 3 3–250
wileyonlinelibrary.com/journal/rcmohn Wiley & Sons, Ltd.
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Table 2. Quantiﬁcation results achieved analyzing 15 urine samples spiked with different concentrations of TDGA, using
both the LC/ESI- and LC/SACI–ESI-MS/MS approaches. The theoretical quantiﬁcation value together with quantiﬁcation
accuracy and precision are also reported
LC/ESI-MS/MS LC/SACI–ESI-MS/MS
Sample
Precision Accuracy Precision Accuracy
(%) (%) (%) (%)
Urine A + 50 ppb 90 49 93 88
Urine A + 200 ppb 80 50 99 92
Urine B + 50 ppb 92 70 91 85
Urine B + 200 ppb 78 68 97 95
Average 85 59 95 90
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